Sciencast Management LP Takes $971,000 Position in Iqvia Holdings Inc (IQV)
Sciencast Management LP purchased a new stake in Iqvia Holdings Inc (NYSE:IQV) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 9,381 shares of the medical research company’s stock, valued at approximately $971,000.
Other institutional investors also recently added to or reduced their stakes in the company. Exxonmobil Investment Management Inc. TX bought a new position in shares of Iqvia during the fourth quarter worth approximately $2,266,000. DnB Asset Management AS bought a new position in shares of Iqvia during the fourth quarter worth approximately $8,813,000. First Citizens Bank & Trust Co. bought a new position in shares of Iqvia during the fourth quarter worth approximately $1,067,000. Franklin Street Advisors Inc. NC bought a new position in shares of Iqvia during the fourth quarter worth approximately $7,446,000. Finally, Nisa Investment Advisors LLC bought a new position in shares of Iqvia during the fourth quarter worth approximately $920,000. 92.34% of the stock is currently owned by hedge funds and other institutional investors.
In other Iqvia news, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $100.00, for a total value of $1,000,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Michael J. Evanisko sold 816 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $100.00, for a total transaction of $81,600.00. The disclosure for this sale can be found here. Insiders sold 30,816 shares of company stock worth $3,093,400 over the last three months. 6.00% of the stock is currently owned by insiders.
Iqvia (NYSE:IQV) last announced its quarterly earnings data on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.34 by ($0.02). The firm had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. Iqvia had a net margin of 13.44% and a return on equity of 13.03%. The business’s revenue was up 10.7% compared to the same quarter last year. During the same period last year, the business earned $1.09 earnings per share. equities analysts anticipate that Iqvia Holdings Inc will post 2.84 EPS for the current fiscal year.
Several research analysts have recently commented on the stock. SunTrust Banks raised shares of Iqvia from a “hold” rating to a “buy” rating in a report on Wednesday, March 7th. Zacks Investment Research cut shares of Iqvia from a “buy” rating to a “hold” rating in a report on Friday, January 19th. ValuEngine raised shares of Iqvia from a “hold” rating to a “buy” rating in a report on Tuesday, February 20th. Mizuho set a $97.00 target price on shares of Iqvia and gave the stock a “hold” rating in a report on Wednesday, January 24th. Finally, TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a report on Wednesday, December 13th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $110.02.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.